Nasal COVID-19 Vaccine Secures Federal Funding for Groundbreaking Clinical Trial
CyanVac LLC is set to begin a federally funded Phase 2b trial this fall for its intranasal COVID-19 vaccine, CVXGA,…
Bringing News as it Unfolds
CyanVac LLC is set to begin a federally funded Phase 2b trial this fall for its intranasal COVID-19 vaccine, CVXGA,…
Mucosal vaccination protects hamsters from SARS-CoV-2-induced clinical disease. (a) Diagram of the experimental design where hamsters were vaccinated with S-RBD…